A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme



Status:Archived
Conditions:Brain Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:December 2010
End Date:October 2012

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Phase 2 Study of MEDI-575 in Adult Subjects With Recurrent Glioblastoma Multiforme


The primary objective of this Phase II study is to evaluate the progression-free survival at
6 months in adult subjects with a first recurrence of Glioblastoma Multiforme who are
treated with MEDI-575.



We found this trial at
8
sites
Clinical Trial Facility in Bronx New York
Bronx, New York
?
mi
from
Bronx, NY
Click here to add this to my saved trials
Clinical Trial Facility in Akron Ohio
Akron, Ohio
?
mi
from
Akron, OH
Click here to add this to my saved trials
Clinical Trial Facility in Allentown Pennsylvania
Allentown, Pennsylvania
?
mi
from
Allentown, PA
Click here to add this to my saved trials
Clinical Trial Facility in Ayer Massachusetts
Ayer, Massachusetts
?
mi
from
Ayer, MA
Click here to add this to my saved trials
Clinical Trial Facility in Bellingham Washington
Bellingham, Washington
?
mi
from
Bellingham, WA
Click here to add this to my saved trials
Clinical Trial Facility in Chattanooga Tennessee
Chattanooga, Tennessee
?
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Clinical Trial Facility in Evanston Illinois
Evanston, Illinois
?
mi
from
Evanston, IL
Click here to add this to my saved trials
Clinical Trial Facility in San Diego California
San Diego, California
?
mi
from
San Diego, CA
Click here to add this to my saved trials